HOME >> BIOLOGY >> NEWS
Argonne scientists determine structure of staph, anthrax enzyme

Researchers at the U.S. Department of Energy's Argonne National Laboratory and the University of Chicago have determined the crystal structure of sortase B, an enzyme found in the bacteria that cause staph and anthrax. While an antibiotic is probably five to seven years away, the structure could provide the first clue in developing a treatment for the infections.

The research is published today in the journal Structure.

It took the researchers 21 days to build the three dimensional model of sortase from the genome. Without the new technology available at Argonne's Structural Biology Center, including the Advanced Photon Source's powerful X-rays to illuminate the structures and the Midwest Center for Structural Genomics' robotic and automation facilities for protein expression, purification and crystallization, the process could have taken several months.

By analyzing genomes, the researchers uncover information that will lead to structure-based or "rational" drug design. The problem is that researchers don't know what half the proteins coded by the genome do or how they work.

Now that the researchers understand the enzyme, they hope to find a way to stop it or at least to slow it down. Sortase attaches proteins to the surface of bacterial pathogens. These proteins help the pathogens survive and flourish.

Bacteria like staph and anthrax need iron to function. But little free iron is available in the blood stream because most of it is bound in red blood cells. So the bacteria develop a mechanism to pry open the red blood cells, and these proteins help them.

"This is actually a very smart mechanism," said Andreji Joachimiak, lead researcher and director of the Structural Biology Center. The process is outlined in an article published in Science last year by Olaf Schneewind of the University of Chicago, which laid the groundwork for the sortase project.

The bacteria open the blood cell, bind the hemoglobin that contains heme
'"/>

Contact: Beth Quill
media@anl.gov
630-252-5549
DOE/Argonne National Laboratory
14-Jul-2004


Page: 1 2 3

Related biology news :

1. Argonne research offers clues to Alzheimers plaques
2. Argonne chemist wins national award for studies of plant energy
3. NIH, Argonne sign agreement
4. Argonne leads new Midwest Center for Structural Genomics
5. Argonne biochips may halt tuberculosis epidemic
6. Argonne Researchers Develops Simple, Inexpensive Method For Cleaning Industrial Waste Streams
7. DNA lends scientists a hand, revealing new chemical reactions
8. Conference at UH opens doors for new scientists, engineers
9. Wisconsin scientists develop quick botox test
10. UCI scientists successfully target key HIV protein; breakthrough may lead to new drug therapies
11. Alaska scientists find Arctic tundra yields surprising carbon loss

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/1/2020)... , ... February 01, 2020 , ... Liver cancer, called ... and about 700,000 die from the disease. HCC is the 5th most common cancer ... among all countries when it comes to incidence of HCC, while China has half ...
(Date:1/28/2020)... PRUSSIA, Pa. and CAMBRIDGE, Mass. (PRWEB) , ... ... ... to solving complex problems for life sciences companies and government agencies, announced that ... life sciences hubs in the country. Tunnell’s Cambridge office will be in the ...
(Date:1/24/2020)... ... January 24, 2020 , ... ... mobilize Colorado’s capital resources to support early-stage bioscience companies in the state. ... have struggled to find the funding they need to innovate and grow. ...
Breaking Biology News(10 mins):
(Date:2/11/2020)... ... February 11, 2020 , ... ... to announce the successful results from a long-term follow-up clinical study of ... interspinous fixation device (INSPAN LLC). Unlike extension block design, the Inspan device ...
(Date:2/5/2020)... ... , ... Rare Disease Day® , held the last day in February ... (NORD), to raise awareness amongst the general public and decision-makers about rare diseases and ... Mystery” rare disease series will be shining the light on Rare Disease ...
(Date:1/28/2020)... WASHINGTON (PRWEB) , ... January ... ... provider of enterprise software solutions for biopharmaceutical R&D, today announced the release ... release reinforces Genedata’s focus on supporting the implementation of Multi-Attribute Methods (MAM) ...
(Date:1/24/2020)... SCOTCH PLAINS, N.J. (PRWEB) , ... January 24, 2020 , ... ... (IFAR) at The Plastic Surgery Center in New Jersey epitomize the notion that plastic ... plastic surgery is typically characterized in popular media. , Over the last 20 years ...
Breaking Biology Technology:
Cached News: